We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





The COVID-19 Pandemic: Primed and Prepared

By CLN Stat
Posted on 14 Dec 2020
Print article
Illustration
Illustration
Late-breaking scientific sessions detail the testing and response landscape, latest science on SARS-CoV-2 virology and therapeutics, quest for vaccines, more effective mobilization against new global health threats.

Seven late-breaking sessions at the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo address the game-changing topic of SARS-CoV-2, exploring the virology and characteristics of this novel virus and the recent landscape of testing and therapeutics. “Each of these scientific sessions will provide attendees a much deeper understanding of the COVID-19 pandemic and shed light on the advantages and disadvantages of the various tests that are being performed for SARS-CoV-2, from molecular to serology,” Paul Jannetto, PhD, DABCC, FAACC, chair of the Annual Meeting Organizing Committee (AMOC), told CLN Stat.

Participants will gain a deeper comprehension of how this virus differs from others and of current treatment strategies.

The postponement of the 2020 Annual Scientific Meeting & Clinical Lab Expo from July to December underscored the importance of providing the latest scientific information on the COVID-19 pandemic, said Jannetto. AMOC wanted to highlight timely and novel research on antibody/antigen testing, therapeutic strategies, and the latest information about a vaccine against SARS-CoV-2.

The panel also wanted to include a general session on virology and diagnostic paradigms, supply chain and laboratory testing issues, and the role of clinical labs in global pandemics. “As a result, the AMOC actively recruited experts in each of these areas who graciously agreed to provide attendees the cutting-edge scientific information around each of these relevant topics,” said Jannetto.

In a special session on Tuesday, December 15, Assistant Secretary of Health Adm. Brett P. Giroir, MD, who coordinates SARS-CoV-2 testing efforts across the Department of Health and Human Services, will discuss the past, present, and future of SARS-CoV-2. This session will take place from 4:30–5:30 p.m. (U.S. Central Standard Time)

Jannetto is also looking forward to the Chair’s Invited Session this year, Pandemic Preparedness: The Role of Clinical Laboratories and Public Health in Controlling Outbreaks Representing a Global Health Threat. His colleague Matthew Binnicker, PhD, director of clinical virology at Mayo Clinic, will be talking about the role of clinical labs and public health in controlling global outbreaks and what laboratories can do to be better prepared for the next pandemic. This presentation takes place on Monday, December 14, from 11 a.m.–12:30 p.m.

Related Links:
2020 AACC Annual Scientific Meeting & Clinical Lab Expo
Annual Meeting Organizing Committee
Pandemic Preparedness: The Role of Clinical Laboratories and Public Health in Controlling Outbreaks Representing a Global Health Threat
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.